Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 1
1983 7
1984 9
1985 1
1986 6
1987 8
1988 6
1989 10
1990 9
1991 9
1992 5
1993 8
1994 13
1995 12
1996 7
1997 15
1998 7
1999 5
2000 7
2001 3
2002 3
2003 8
2004 12
2005 11
2006 5
2007 7
2008 2
2009 5
2010 7
2011 5
2012 1
2013 5
2014 4
2015 4
2016 6
2017 4
2018 4
2019 7
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Results by year
Filters applied: . Clear all
Page 1
Managing toxicities of high-dose interleukin-2.
Schwartz RN, Stover L, Dutcher JP. Schwartz RN, et al. Among authors: dutcher jp. Oncology (Williston Park). 2002 Nov;16(11 Suppl 13):11-20. Oncology (Williston Park). 2002. PMID: 12469935 Free article. Review.
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. Haas NB, et al. Among authors: dutcher jp. Lancet. 2016 May 14;387(10032):2008-16. doi: 10.1016/S0140-6736(16)00559-6. Epub 2016 Mar 9. Lancet. 2016. PMID: 26969090 Free PMC article. Clinical Trial.
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
Buchbinder EI, Dutcher JP, Daniels GA, Curti BD, Patel SP, Holtan SG, Miletello GP, Fishman MN, Gonzalez R, Clark JI, Richart JM, Lao CD, Tykodi SS, Silk AW, McDermott DF. Buchbinder EI, et al. Among authors: dutcher jp. J Immunother Cancer. 2019 Feb 18;7(1):49. doi: 10.1186/s40425-019-0522-3. J Immunother Cancer. 2019. PMID: 30777131 Free PMC article.
"Pseudoprogression": more than semantics.
Dutcher JP. Dutcher JP. Cancer Immunol Immunother. 2018 Sep;67(9):1473-1474. doi: 10.1007/s00262-018-2208-y. Epub 2018 Jul 18. Cancer Immunol Immunother. 2018. PMID: 30022219 No abstract available.
Interleukin-2 Can Cure Kidney Cancer.
Dutcher JP, Wiernik PH. Dutcher JP, et al. Oncologist. 2018 Sep;23(9):e107. doi: 10.1634/theoncologist.2018-0038. Epub 2018 Aug 13. Oncologist. 2018. PMID: 30104291 Free PMC article.
250 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page